

Treace Medical Concepts (NASDAQ:TMCI) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Treace Medical Concepts (NASDAQ:TMCI) through any online brokerage.
Other companies in Treace Medical Concepts’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Treace Medical Concepts has a consensus price target of $6.48.
The stock price for Treace Medical Concepts (NASDAQ: TMCI) is $4.31 last updated November 9, 2026 at 4:51 AM EST.
There are no upcoming dividends for Treace Medical Concepts.
Treace Medical Concepts does not have any upcoming earnings scheduled.
There is no upcoming split for Treace Medical Concepts.
Treace Medical Concepts is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure...